BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18430455)

  • 1. Biliary neoplasia with extensive intraductal spread associated with liver cirrhosis: a hitherto unreported variant of biliary intraepithelial neoplasia.
    Aishima S; Nishihara Y; Tsujita E; Taguchi K; Soejima Y; Taketomi A; Ikeda Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2008 Jun; 39(6):939-47. PubMed ID: 18430455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
    Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
    Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.
    Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y
    Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile duct changes in different etiologic types of end-stage chronic liver disease: a study on native explant livers.
    Jain D; Nayak NC
    J Clin Pathol; 2012 Apr; 65(4):348-51. PubMed ID: 22135029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
    Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
    Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of mucin glycoproteins and cytokeratins in intrahepatic cholangiocarcinoma].
    Zhao SM; Zhu XZ; Ji Y; Hou J
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):749-53. PubMed ID: 19094709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
    Torbenson M; Yeh MM; Abraham SC
    Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis.
    Sasaki M; Nakanuma Y; Ho SB; Kim YS
    J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis.
    Zen Y; Quaglia A; Heaton N; Rela M; Portmann B
    Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary cholangiocarcinoma and atypical biliary epithelial lesions confused with intrabiliary extension of metastatic colorectal carcinoma.
    Itatsu K; Fujii T; Sasaki M; Zen Y; Nakanuma Y
    Hepatogastroenterology; 2007; 54(75):677-80. PubMed ID: 17591040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver.
    Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y
    Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Glut-1 expression in cholangiocarcinoma, benign biliary lesions and hepatocellular carcinoma.
    Zimmerman RL; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(4):689-92. PubMed ID: 12066193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.